News Medicine

Self-Destructing Cancer Cells with Diet

A groundbreaking study has found that a special amino acid diet can cause aggressive cancer cells to self-destruct. Researchers from the University of North Carolina

 News Medicine

Neuralink to Test Brain Chips on Humans

Neuralink, a company founded by Elon Musk, has received approval for a clinical trial of its Brain-Control Interface (BCI) with humans. The implant aims to

 News Medicine

Fluoride-free toothpaste with cavity protection

A new toothpaste containing hydroxyapatite has been found to be just as effective in preventing cavities as traditional fluoride-based products. Unlike fluoride, hydroxyapatite does not

 News Medicine

Cancer cured by genetically modified herpes

A cancer patient who was deemed incurable has been cured using genetically modified herpes viruses. The man has been cancer-free for two years. Scientists at

 News Medicine

Permanent Cure for Blood Disease

A groundbreaking gene therapy injection has successfully cured people with hemophilia, a genetic disorder that impairs the body’s ability to clot blood. Hemophilia patients lack

 News Medicine

Stem Cell Therapy Cures Type 1 Diabetes

In a groundbreaking development, a 64-year-old man with type 1 diabetes has been cured through stem cell therapy. This is the first time that a

 News Medicine

First Patient Receives Anti-Cancer Pill

A new anti-cancer pill called AOH1996 has been given to its first patient, with promising results reported by researchers at the City of Hope, one

 News Medicine

Successful Human Gene Therapy Trial

A new gene therapy for Hemophilia A, a blood clotting disorder, has shown promising results in a clinical trial. Hemophilia A patients have limited production

 News Medicine

Paxlovid: Highly Effective COVID Medication

Pfizer’s combination drug, Paxlovid, has been found to reduce the risk of hospitalization and death by 89% in high-risk COVID-19 patients. The drug is expected

 News Medicine

mRNA-based HIV vaccine study

Moderna, a biotechnology company, has begun a ten-month Phase I study with 56 participants to test the first mRNA-based vaccine against HIV. The study aims